NO-Releasing Metal-Organic Framework-Based Composite Coatings with Heparin-Mimicking Copolymers on Titanium...

Area of Science:

• Biomaterials Science
• Vascular Biology
• Nanotechnology

Background:

• Nitric oxide (NO) exhibits anticoagulant and antiproliferative properties, making it promising for anticoagulation therapy.
• Copper-based metal-organic frameworks (CuBTTri) can generate NO, but their effects on vascular cells need investigation.
• Titanium substrates are widely used in biomedical applications, necessitating improved surface coatings for enhanced biocompatibility.

Purpose of the Study:

• To develop a composite coating on titanium substrates that integrates NO release with enhanced cytocompatibility.
• To investigate the selective modulation of vascular cell behavior by controlling NO release rates.
• To assess the impact of heparin-mimicking copolymers on the cytocompatibility of the composite coating.

Main Methods:

• Codeposition of polydopamine, polyethylenimine, and CuBTTri on titanium substrates.
• Incorporation of heparin-mimicking copolymers to improve cytocompatibility.
• Regulation of NO release rates and cytotoxicity by adjusting CuBTTri content.

Main Results:

• Heparin-mimicking copolymers enhanced cytocompatibility with human umbilical vein endothelial cells.
• NO released from CuBTTri effectively inhibited the proliferation of human umbilical vein smooth muscle cells.
• The composite coating demonstrated selective modulation of vascular cell behavior.

Conclusions:

• A composite coating integrating NO-releasing CuBTTri and heparin-mimicking copolymers was successfully developed.
• This coating offers a promising strategy for modulating vascular cell responses in biomedical applications.
• The developed material selectively controls endothelial and smooth muscle cell behavior, paving the way for advanced anticoagulation therapies.